The 20 Best Marginal Zone Lymphoma (MZL) Doctors Near Me in Falls Church, VA

Dr. Jennifer DeSimone is a specialty care physician board certified in dermatology. She joined Inova Medical Group with 5 years of clinical experience. She has a special interest in management of cutaneous lymphomas, skin cancer in organ transplant recipients and other complex skin cancers. Most recently Dr. DeSimone served as a Director of Cutaneous Lymphoma. Dr. DeSimone became interested in lymphomas of the skin because of the rarity of the disease and the need for greater understanding of its origin and development of more effective therapy. Her goal is to help educate her patients about skin cancer etiology, management and importantly, prevention. A native of Northern Virginia, Dr. DeSimone currently resides in Fairfax County with her husband and two children. In her spare time she enjoys cooking, entertaining, and trail running. Dr. Desimone is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides, T-Cell Lymphoma, and Lymphomatoid Papulosis.

Abbas Tuli is a Radiologist and a Nuclear Medicine provider practicing medicine in Fairfax, Virginia. Dr. Tuli is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Pleurisy, Pleural Effusion, Angiomyoma, and Uterine Fibroids.

Danielle Shafer is a Hematologist and an Oncologist practicing medicine in Fairfax, Virginia. Dr. Shafer is rated as an Advanced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Bone Marrow Aspiration, and Myringotomy.

Richard Rizzo is a Radiologist practicing medicine in Fairfax, Virginia. Dr. Rizzo is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Visceromegaly, Splenomegaly, Folliculitis, and Boils.

Aaron Stack is a Radiologist practicing medicine in Annandale, Virginia. Dr. Stack is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Primary Lymphoma of the Brain, Classical Hodgkin Lymphoma, Neuroendocrine Tumor, and Lung Nodules.

Aditya Halthore, MD, serves as Assistant Professor in the Department of Radiation Oncology and Molecular Radiation Sciences and Director of Safety and Quality at the Johns Hopkins University School of Medicine. Listen to Dr. Halthore's On Target podcast episode to learn more about his work. Dr. Halthore is an expert in proton therapy and specializes in genitourinary and thoracic cancers. His specific interests include prostate, bladder, lung, esophageal, and thymic cancers, and he is committed to developing personalized treatment strategies for every patient. Dr. Halthore was previously recognized as a Howard Hughes Medical Institute (HHMI)/National Institutes of Health (NIH) Scholar and his research interests include grant funded clinical trials focused on the novel utilization of radiation and imaging techniques, such as spatial fractionation (proton GRID) therapy for the treatment of bulky cancers. He is also involved in using dual-energy CT and functional MRI studies that aim to improve functional radiation planning and the assessment of radiation-induced changes. As an educator, Dr. Halthore serves as Course Director for the Johns Hopkins Proton Therapy Certificate Program. He actively participates in student, resident, and fellow lectureship and mentorship across the Johns Hopkins health system. Dr. Halthore participates in several national-level initiatives including as a member of the American Society of Therapeutic Radiation Oncology (ASTRO) Guidelines Subcommittee and as a board member and ASTRO liaison to the Medical Dosimetry Certification Board (MDCB). Dr. Halthore is rated as an Advanced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Small Cell Lung Cancer (SCLC), Marginal Zone Lymphoma (MZL), and Familial Prostate Cancer. Dr. Halthore is board certified in American Board Of Radiology.

Marie Kate Gurka, M.D., is a radiation oncologist in the Department of Radiation Oncology at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and a clinical associate in the Department of Radiation Oncology at The Johns Hopkins Hospital. Dr. Gurka has expertise in radiation treatment for breast cancer and gynecologic cancers. Dr. Gurka earned her medical degree from Virginia Commonwealth University and completed a residency in radiation oncology at Georgetown University Hospital. She previously served as an instructor in the Department of Radiation Oncology at University of Louisville and has conducted both clinical and basic science research. Her work has been recognized by the American Society for Radiation Oncology (ASTRO), and the American Society of Clinical Oncology (ASCO), and it has been cited in various lectures, research articles, and textbooks. Washingtonian Magazine and Bethesda Magazine have repeatedly named Dr. Gurka a Top Doctor. Selected Publications Oermann EK, Bhandari R, Chen V, Lebec G, Gurka M, Lei S, Chen L, Suy, S, Azumi N, Berkowitz F, Kalhorn C, McGrail K, Collins BT, Jean W, Collins SP. Five Fraction Image-Guided Radiosurgery for Primary and Recurrent Meningiomas. Frontiers in Radiation Oncology. 2013; 3: 213. Gurka MK, Collins SP, Slack R, Tse G, Charabaty A, Ley L, Berzcel L, Lei S, Suy S, Haddad N, Jha R, Johnson CD, Jackson P, Marshall JL, Pishvaian MJ. Stereotactic Body Radiation Therapy with Concurrent Full-Dose Gemcitabine for Locally Advanced Pancreatic Cancer: A Pilot Trial Demonstrating Safety. Radiation Oncology. 2013; 8: 44. Gurka MK, Kim C , Carroll J, Charabaty A, Haddad M, Jackson P, Collins SP, Marshall J, Pishvaian MK, Unger KR. Stereotactic Body Radiation Therapy (SBRT) combined with chemotherapy for unresected pancreatic adenocarcinoma. American Journal of Clinical Oncology. 2014; 152-157. Gurka MK, Horne ZD, Ju A, Chen L, Lei S, Batipps GP, Kowalczyk K, Bandi G, Pahira J, McGeagh KG, Collins BT, Krishnan P, Suy S, Dritschilo A, Lynch JH, Collins SP. Hematuria Following Stereotactic Body Radiation Therapy (SBRT) for Clinically Localized Prostate Cancer. Radiation Oncology. 2015; 10:44. Gurka MK, Pender D, Chuong P, Fouts B, Sebelov A, McNally M, Mezera M, Woo SY, McNally R. Identification of pancreatic tumors in vivo with ligand-targeted, pH responsive mesoporous silica nanoparticles by multispectral optoacoustic tomography. Journal of Controlled Release. 2016; 231:60-67. Dr. Gurka is rated as an Advanced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Intraductal Papilloma, Gliomatosis Cerebri, and Marginal Zone Lymphoma (MZL). Dr. Gurka is board certified in American Board Of Radiology.

Robert Christie is a Hematologist and an Oncologist practicing medicine in Arlington, Virginia. Dr. Christie is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 65 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Paget Disease of the Breast, and Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET).

John Feigert is a Hematologist and an Oncologist practicing medicine in Arlington, Virginia. Dr. Feigert is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 65 other conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Familial Colorectal Cancer, Multiple Myeloma, and Chronic Lymphocytic Leukemia (CLL).

Keeran Sampat is a Hematologist and an Oncologist practicing medicine in Arlington, Virginia. Dr. Sampat is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 54 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Familial Colorectal Cancer, Colorectal Cancer, and Paget Disease of the Breast.

Janakiraman Subramanian is an Oncologist practicing medicine in Fairfax, Virginia. Dr. Subramanian is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Bone Marrow Aspiration, and Tissue Biopsy.

Dr. Raymond Wadlow is a specialty care physician board certified in medical oncology and internal medicine. He has a special interest in gastrointestinal oncology. Dr. Wadlow joined Inova Health System in 2020 and has been practicing since 2006. A native of Charlottesville, VA, Dr. Wadlow resides in Fairfax, VA, with his wife and three children. Outside of work, he enjoys cycling, traveling and visiting museums. Dr. Wadlow is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Pancreatic Cancer, Familial Colorectal Cancer, Familial Pancreatic Cancer, and Pancreaticoduodenectomy.

Dr. Tobias Chapman is a specialty care physician board certified in radiation oncology. He joined Inova Schar Cancer Institute in 2019 with more than eight years of clinical experience. Prior to joining Inova Schar, he served as faculty at Harvard. Dr. Chapman is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, HER-2 Positive Breast Cancer, and Metastatic Brain Tumor.

Dr. Sarah Gao is a specialty care physician board eligible in radiation oncology. She joined Radiation Oncology Associates in 2022. Dr. Gao is trained in all aspects of radiation oncology, and her practice focuses on the treatment of all types of cancers with an additional focus on the treatment of breast, gynecological, and head and neck malignancies. Dr. Gao grew up in California and attended California State University in Los Angeles through the early entrance program, graduating magna cum laude with a degree in biochemistry. She went on to receive her medical degree from Yale School of Medicine in New Haven, CT, where she was a recipient of the Hirsch and Hsiung Fellowship for medical research. She completed her radiation oncology residency at Yale and served as chief resident. Dr. Gao has experience across a variety of treatment modalities including intensity-modulated radiation therapy, volumetric modulated arc therapy, stereotactic body radiotherapy, Gamma Knife radiosurgery, gynecologic brachytherapy, total skin electron therapy and orthovoltage therapy. During her training, Dr. Gao’s research endeavors focused on using data science to further personalize the treatment of cancer patients. She has experience creating and managing clinical databases, performing advanced statistical analyses, and building supervised machine learning models. She has given multiple oral presentations at national meetings and has authored numerous peer-reviewed publications, book chapters and editorials. Dr. Gao sees patients at Inova Schar Cancer Institute in Fairfax, VA, and at Potomac Radiation Oncology in Woodbridge, VA. Outside the clinic, Dr. Gao enjoys reading, listening to music, trying new recipes and spending time with family. Dr. Gao is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses HER-2 Positive Breast Cancer, Metastatic Brain Tumor, Prostate Cancer, Familial Prostate Cancer, and Lymphadenectomy.

Raymund Cuevo is an Internal Medicine provider practicing medicine in Fairfax, Virginia. Dr. Cuevo is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Burkitt Lymphoma, Acute Myeloid Leukemia (AML), Lung Cancer, and Bone Marrow Aspiration.

Dr. Lonika Majithia is currently the Medical Director of Brachytherapy and Director of Educational Programs at Radiation Oncology Associates, and is board certified in radiation oncology. She joined Radiation Oncology Associates in 2016. Her clinical interests include gynecologic, breast, CNS, GI, thoracic and hematologic malignancies. Dr. Majithia is experienced with multiple radiotherapy techniques including volumetric modulated arc therapies (VMAT), intensity modulated radiation therapy (IMRT), stereotactic body radiotherapy, Gamma Knife and CyberKnife Radiosurgery, intra-operative radiotherapy (IORT), eye plaque brachytherapy, and prostate and gynecologic brachytherapy, including High Dose Rate (HDR) brachytherapy. Dr. Majithia grew up in Albuquerque, NM. She graduated magna cum laude from the University of New Mexico with dual bachelor’s degrees in biology and physics. She was awarded the UNM Merit Scholarship and actively participated in physics and basic science research. She completed her medical training at the University of New Mexico where she was elected to the Alpha Omega Alpha Medical Honor Society. She completed her preliminary medicine internship at the Medical College of Wisconsin in Milwaukee, WI and her radiation oncology residency at The Ohio State University in Columbus, OH. She served as Chief Resident during her last year of residency and remained active in academic pursuits including research and medical education. During her residency, she presented multiple abstracts and presentations at the American Society for Radiation Oncology (ASTRO) annual meetings and American Society of Clinical Oncology (ASCO) meetings. She has published book chapters, written retrospective review articles, and assisted in the development of a phase I clinical trial in hematologic malignancies. During her residency, she also completed a master’s degree in medical sciences. Dr. Majithia is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). She is also highly rated in 37 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Metastatic Brain Tumor, Neuroendocrine Carcinoma of the Cervix, and Cervical Cancer.

Dr. Michael J. Eblan is a specialty care physician board certified in radiation oncology at Radiation Oncology Associates, which he joined in 2016. Prior to joining Radiation Oncology Associates, he completed his internal medicine internship and radiation oncology residency at the University of North Carolina at Chapel Hill. There, he served as chief resident, led quality and safety initiatives to improve patient care, and designed prospective clinical investigations of circulating tumor cells as a novel biomarker for radiation treatment response. During his residency, Dr. Eblan also completed additional training in CyberKnife robotic radiosurgery and earned a Lean Six Sigma Yellow Belt certification. Much of his research has focused on the effects of radiation on normal tissues and the development of nanotherapeutics to improve the efficacy of chemoradiotherapy and immunotherapy at the Carolina Center of Cancer Nanotechnology Excellence. Dr. Eblan is trained in all aspects of radiation oncology and has particular clinical interest in thoracic, gastrointestinal, breast, prostate, brain, head and neck, hematologic, and pediatric malignancies. He is experienced with multiple radiotherapy techniques, including proton beam therapy, volumetric modulated arc therapies, intensity-modulated radiation therapy, stereotactic body radiotherapy, CyberKnife radiosurgery, intraoperative radiotherapy, and prostate and gynecologic brachytherapy, including high-dose-rate brachytherapy. His work has been recognized by the American Society for Radiation Oncology, the American Association for Cancer Research, the Conquer Cancer Foundation and the American Society of Clinical Oncology. Dr. Eblan grew up in Fairfax County and graduated with distinction as an Echols Scholar from the University of Virginia, receiving dual degrees in biology and economics. He then trained at the National Institutes of Health in Bethesda, MD, through a postbaccalaureate Intramural Research Training Award and published numerous research articles on genetic alterations contributing to human disease, including publication in the New England Journal of Medicine. He received his medical degree from the University of Pennsylvania School of Medicine, where he was awarded the Ruth L. Kirschstein National Research Service Award to study cancer biology and proton radiotherapy. Dr. Eblan is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, Prostate Cancer, and Familial Prostate Cancer.

Firas Al is an Internal Medicine specialist and a Gastroenterologist practicing medicine in Fairfax, Virginia. Dr. Al is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Bile Duct Obstruction, Cholestasis, Bile Duct Stricture, Endoscopy, and Pancreaticoduodenectomy.

Mather Director, Radiation Oncology Research Inova Radiation Oncology Inova Schar CancerDr. Avani Rao is a specialty care physician board certified in radiation oncology who serves as the Director of Research, Proton Therapy Fellowship Director and lead physician in pediatric radiation oncology. She joined Radiation Oncology Associates in 2020. Her areas of interest are pediatric, gynecologic, gastrointestinal and breast malignancies.Dr. Rao graduated from Yale University magna cum laude with a bachelor’s degree in molecular, cellular and developmental biology. She completed medical school, her internal medicine internship and her radiation oncology residency at Johns Hopkins School of Medicine. She was nominated to Alpha Omega Alpha during medical school, and during her residency, Dr. Rao served as Chief Resident. She pursued additional fellowship training at the University of Maryland to gain specific expertise in proton therapy. Dr. Rao has received several awards supporting her research and recognizing her clinical excellence and has published more than 40 peer-reviewed publications. Dr. Rao is board certified in radiation oncology. Dr. Rao is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). She is also highly rated in 38 other conditions, according to our data. Her clinical expertise encompasses Endometrial Stromal Sarcoma, Endometrial Cancer, Metastatic Brain Tumor, and Prostate Cancer.

Dr. C. Bryce Johnson is a specialty care physician board certified in radiation oncology. He joined Inova Health System in 2021 and has been practicing since 2017. Prior to joining Inova, Dr. Johnson completed his radiation oncology residency at Memorial Sloan Kettering Cancer Center. Dr. Johnson is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Metastatic Brain Tumor, Pleuropulmonary Blastoma, and Familial Prostate Cancer.